Subscribe to our newsletter

VisiVite needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at anytime.

Recent Articles

More like this

Common anti-depresant may lower risk of AMD

Study findings were recently published in Proceedings of the National Academy of Sciences of the United States of America that highlight the potential of the antidepressant fluoxetine to lower the risk of developing dry age-related macular [...]

New drug for dry AMD shows promise in trials

Allegro Ophthalmics revealed data from their phase 2a study of their drug risuteganib in treating patients with intermediate dry age-related macular degeneration.

Anti-depressant may be effective in slowing macular degeneration

Researchers have identified the common antidepressant fluoxetine (Prozac) as a direct NLRP3 inhibitor to treat dry age-related macular degeneration. NLRP3 and ASC are inflammasome components that are known to be factors in the development of macular [...]

New imaging can detect early signs of Geographic Macular Degeneration

Study findings were recently posted in Progress in Retinal Eye Research that found that Detection of Apoptosis in Retinal Cells (DARC) imagining technology is able to identify areas of the eye that are showing signs of geographic atrophy (GA).
More recent articles
WANT SOMETHING AMAZING?

Ultimate insiders Guide to Eye Health

Newly updated popular book by Dr. Paul Krawitz - now available as a FREE DOWNLOAD. Includes AREDS2 study results and explanations, the 'Ultimate Insider's Guide to Eye Health" contains critical information about common eye problems, including macular degeneration, dry eye syndrome, cataract surgery, diabetic retinopathy, and contact lenses.

Get this ebook now